{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:02:48Z","timestamp":1776351768340,"version":"3.51.2"},"reference-count":31,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2025,7,28]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study examined the association of self-reported HIV status with history of oral pre-exposure prophylaxis (PrEP) use among reproductive-age women from Lesotho.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study analysed a sample of 6413 women from the 2023\u201324 Lesotho Demographic and Health Survey (LDHS) data. The data were collected between November 2023 and February 2024. Categorical data were analysed with percentages and \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests. In addition, ever use of oral PrEP and covariates of self-reported HIV infection were investigated using binary multivariable multilevel logistic regression. HIV infection data were self-reported by the women based on their most recent HIV test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The weighted prevalence of self-reported HIV infection among women was 22.1% (95% CI 20.6% to 23.7%). Among women who ever used oral PrEP, the prevalence of self-reported HIV infection was 13.4% (95% CI 9.9% to 17.9%), but was 24.0% (22.0% to 26.1%) among women who have never used. History of oral PrEP use was associated with 62.0% reduction in the odds of self-reported HIV infection (adjusted OR (aOR) 0.38; 95% CI 0.28 to 0.51). Respondents who have heard of a sexually transmitted infection (STI) have 27.0% reduction in the odds of self-reported HIV infection when compared with those who have not heard of an STI (aOR 0.73; 95% CI 0.59 to 0.90). Women aged 25+ years at first sex had 60.0% reduction in the odds of self-reported HIV infection, when compared with those &lt;18 years at first sex (aOR 0.40; 95% CI 0.19 to 0.84). Women with multiple total lifetime number of sexual partners had higher odds of self-reported HIV infection, when compared with those with single lifetime number of sexual partner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HIV infection among women in Lesotho remains high. Having a history of oral PrEP use was associated with lower odds of self-reported HIV infection. Stakeholders in healthcare should promote oral PrEP interventions and design programmes for HIV prevention among women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2024-056478","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:20:40Z","timestamp":1754414440000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association of self-reported HIV infection with oral pre-exposure prophylaxis use among women of reproductive age in Lesotho: evidence from mixed-effects estimates of nationally representative data"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2372-3020","authenticated-orcid":false,"given":"Michael","family":"Ekholuenetale","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"2026041607151270000_102.3.159.1","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","article-title":"Global, regional, and national burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021","volume":"11","author":"Carter","year":"2024","journal-title":"Lancet HIV"},{"key":"2026041607151270000_102.3.159.2","unstructured":"The global health observatory. Available: https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids [Accessed 22 Dec 2024]."},{"key":"2026041607151270000_102.3.159.3","unstructured":"UNAIDS . Fast-track - ending the AIDS epidemic by 2030. Joint United Nations Programme on HIV\/AIDS (UNAIDS). 2014. Available: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2686_WAD2014report_en.pdf"},{"key":"2026041607151270000_102.3.159.4","unstructured":"HIV\/AIDS data and statistics: lesotho. \u2018UNAIDS data report\u2019 2023. Available: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/lesotho [Accessed 22 Dec 2024]."},{"key":"2026041607151270000_102.3.159.5","unstructured":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, Licence: CC BY-NC-SA 3.0 IGO. Geneva World Health Organization; 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240031593 [accessed 22 Dec 2024]"},{"key":"2026041607151270000_102.3.159.6","unstructured":"World Health Organization . World health statistics 2018: monitoring health for the SDGs: sustainable development goals. 2018."},{"key":"2026041607151270000_102.3.159.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"2026041607151270000_102.3.159.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"2026041607151270000_102.3.159.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-021-01348-8","article-title":"\u201cPrEP\u201ding for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women","volume":"21","author":"Pasipanodya","year":"2021","journal-title":"BMC Womens Health"},{"key":"2026041607151270000_102.3.159.10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/15381501.2016.1166090","article-title":"Barriers to Condom Use: Results for Men and Women Enrolled in HIV Risk Reduction Trials in Outpatient Drug Treatment","volume":"15","author":"Campbell","year":"2016","journal-title":"J HIV AIDS Soc Serv"},{"key":"2026041607151270000_102.3.159.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137055","article-title":"Factors Associated with HIV Prevalence and HIV Testing in Sierra Leone: Findings from the 2008 Demographic Health Survey","volume":"10","author":"Brima","year":"2015","journal-title":"PLoS One"},{"key":"2026041607151270000_102.3.159.12","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-555","article-title":"Spatial analysis of factors associated with HIV infection among young people in Uganda, 2011","volume":"14","author":"Chimoyi","year":"2014","journal-title":"BMC Public Health"},{"key":"2026041607151270000_102.3.159.13","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl218"},{"key":"2026041607151270000_102.3.159.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1181"},{"key":"2026041607151270000_102.3.159.15","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-6-248","article-title":"HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam","volume":"6","author":"Tran","year":"2006","journal-title":"BMC Public Health"},{"key":"2026041607151270000_102.3.159.16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s40121-020-00336-z","article-title":"Seroprevalence and Determinants of Human Immunodeficiency Virus Infection Among Women of Reproductive Age in Mozambique: A Multilevel Analysis","volume":"9","author":"Ekholuenetale","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2026041607151270000_102.3.159.17","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179397","article-title":"Socioeconomic Inequalities in Human Immunodeficiency Virus (HIV) Sero-Prevalence among Women in Namibia: Further Analysis of Population-Based Data","volume":"18","author":"Ekholuenetale","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026041607151270000_102.3.159.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048478","article-title":"Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations","volume":"12","author":"O Murchu","year":"2022","journal-title":"BMJ Open"},{"key":"2026041607151270000_102.3.159.19","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.18.4.19983","article-title":"Beyond \u201cgetting drugs into bodies\u201d: social science perspectives on pre-exposure prophylaxis for HIV","volume":"18","author":"Auerbach","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"2026041607151270000_102.3.159.20","unstructured":"Ministry of Health [Lesotho] and ICF . Lesotho demographic and health survey 2023\u201324: key indicators report. Maseru, Lesotho, and Rockville, Maryland, USA Ministry of Health and ICF; 2024. Available: https:\/\/www.dhsprogram.com\/publications\/publication-FR391-DHS-Final-Reports.cfm [accessed 23 Dec 2024]"},{"key":"2026041607151270000_102.3.159.21","unstructured":"The DHS program - lesotho: standard DHS, 2023-24 dataset. Available: https:\/\/www.dhsprogram.com\/data\/dataset\/Lesotho_Standard-DHS_2023.cfm?flag=1 [Accessed 17 Jul 2025]."},{"key":"2026041607151270000_102.3.159.22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09720502.2010.10700699","article-title":"Collinearity diagnostics of binary logistic regression model","volume":"13","author":"Midi","year":"2010","journal-title":"J Interdiscip Math"},{"key":"2026041607151270000_102.3.159.23","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9868.00353"},{"key":"2026041607151270000_102.3.159.24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/10705511.2013.797841","article-title":"Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling (2nd Edition)","volume":"20","author":"Stawski","year":"2013","journal-title":"Struct Equ Modeling"},{"key":"2026041607151270000_102.3.159.25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi017"},{"key":"2026041607151270000_102.3.159.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271431","article-title":"High HIV prevalence and associated factors in Lesotho: Results from a population-based survey","volume":"17","author":"Schwitters","year":"2022","journal-title":"PLoS One"},{"key":"2026041607151270000_102.3.159.27","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-224","article-title":"Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa","volume":"11","author":"Coburn","year":"2013","journal-title":"BMC Med"},{"key":"2026041607151270000_102.3.159.28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0000000000000207","article-title":"Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women","volume":"11","author":"Thomson","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2026041607151270000_102.3.159.29","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","article-title":"HIV pre-exposure prophylaxis: scaling up for impact now and in the future","volume":"6","author":"Bavinton","year":"2021","journal-title":"Lancet Public Health"},{"key":"2026041607151270000_102.3.159.30","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2021.667823","article-title":"Integrating Oral PrEP Into Family Planning Services for Women in Sub-saharan Africa: Findings From a Multi-Country Landscape Analysis","volume":"3","author":"Bhavaraju","year":"2021","journal-title":"Front Reprod Health"},{"key":"2026041607151270000_102.3.159.31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgs.17805","article-title":"Delayed medical care and its perceived health impact among US older adults during the COVID-19 pandemic","volume":"70","author":"Zhong","year":"2022","journal-title":"J Am Geriatr Soc"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2024-056478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:15:32Z","timestamp":1776348932000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2024-056478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,16]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/sextrans-2024-056478"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2024-056478","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}